Avian Influenza (H5N1) Virus by Dr Praveen Gupta, Principle Director and Chief of Neurology, Fortis Hospital.

▴ Avian Influenza
Going forward, leveraging the WHO’s initiative if India develops and produces its own vaccines using mRNA, we would be able to benefit from the technology that instructs the body to produce a unique protein that stimulates an immune response, teaching it to defend against the infection.

By Dr Praveen Gupta, Principle Director and Chief of Neurology, Fortis Hospital

There is concern that the avian influenza (H5N1) virus, or bird flu, could lead to the next pandemic. The government recently increased vigilance against the spread of bird flu following WHO warnings of heightened transmission risks and potential human infections. The virus can cause severe complications, including neurological issues, posing significant health risks. It is high time for us to take the situation seriously as in West Bengal, we have already witnessed a human transmission. The virus causes severe complications including neurological ones.

Severity of the situation can be understood with the fact that this week WHO announced a new project to accelerate the development of vaccines for human bird flu infections for low- and middle-income countries, using cutting-edge messenger RNA technology. WHO has taken consideration of vaccine equity and established the mRNA Technology Transfer Programme,” and this will help India significantly. 

From neurology point of view also the virus can be life-threatening as it has demonstrated neurotropism and that can infect the central nervous system. Severe cases may experience encephalitis, yet another potentially life-threatening inflammation of the brain. Altered mental status, seizures, and even coma are main symptoms that indicate the virus has infected the brain. We can say that these neurological manifestations result from direct viral invasion of the brain, as well as from an excessive immune response leading to inflammation and tissue damage. Early recognition and management of these complications are crucial, as they can significantly impact the prognosis and outcomes.

Going forward, leveraging the WHO’s initiative if India develops and produces its own vaccines using mRNA, we would be able benefit from the technology that instructs the body to produce a unique protein that stimulates an immune response, teaching it to defend against the infection.

Tags : #

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-



Trending Now

The Value of Risk Communication in Public HealthOctober 08, 2026
What Makes a Reliable Health Screening Programme?October 08, 2026
How Language Access Can Improve Patient Communication in Indian HealthcareOctober 07, 2026
Why Health Literacy Matters in Preventive HealthcareOctober 07, 2026
Improving Follow-Up After Diagnostic Testing: Where Systems Commonly Break DownOctober 07, 2026
Improving Follow-Up After Diagnostic Testing: Where Systems Commonly Break DownOctober 07, 2026
How Community Health Workers Support Preventive Care DeliveryOctober 07, 2026
AI in India's Emergency Departments: Reducing Diagnostic DelaysOctober 06, 2026
AI and Patient Consent in India: Who Is Responsible?October 06, 2026
Wearable Technology in Pregnancy: Benefits and LimitsOctober 06, 2026
Remote Monitoring for High-Risk Pregnancies in IndiaOctober 06, 2026
Fortis Escorts Faridabad Launches ‘Sehat Express’ Mobile Bus for Accessible Doorstep Cancer Screening in association with Faridabad Industries Association Charitable Society and Rotary Club FaridabadOctober 05, 2026
Advanced Thrombectomy Saves 60-Year-Old Woman After Severe Heart Attack at KIMS SaveeraOctober 05, 2026
Constipation, Bloating and Long Sitting Hours: Doctors at RG Hospitals Delhi Warn Urban Professionals Not to Ignore Gut ProblemsOctober 05, 2026
Fermenta – Centre of Excellence for Food Fortification Inaugurated at NIFTEM-T, ThanjavurOctober 05, 2026
Alzheimer’s Dementia: Recognising the Signs, Diagnosing Earlier and Changing the Future of Brain HealthOctober 05, 2026
Man Matters Hairfall Case Study 2026: 7 Lakh+ Consultations Reveal How Hair Loss Changes With AgeOctober 05, 2026
Medication Reconciliation: A System-Level Step for Safer Transitions of CareOctober 05, 2026
The Role of Clinical Pharmacists in Safer Medication UseOctober 05, 2026
Nanavati Max Hospital Hosts Max Cancer Congress 2026, Bringing Together Oncology Experts to Explore the Future of Cancer Care October 01, 2026